MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0117411
Den Mark Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹23.71 Cr
▲ 317% YoY
Net loss · FY 2024
₹15.96 Cr
Net margin -67.3%
EBITDA · FY 2024
-₹13.52 Cr
EBITDA margin -57%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹44.73 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
137
Provident fund records
Directors on board
2
As per MCA filings
About Den Mark Pharmaceuticals Private Limited
Data last updated:
Den Mark Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2021PTC372188. Its GSTIN is 27AAICD9226A1ZT (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹44.73 Lakh. It is led by directors Samad Hussain Patanwala and Shahnazar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1st Floor Harish Textiles Parsi Panchayat Road Andheri East Mumbai City, Maharashtra, India – 400069.
As per the financials filed for FY 2024, the company reported a revenue of ₹23.71 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹15.96 Cr (net margin -67.3%) and EBITDA of -₹13.52 Cr (EBITDA margin -57%).
The company has about 137 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Den Mark Pharmaceuticals. Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
Den Mark Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0117411). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website denmarkpharma.com.
Company details
CIN U24304MH2021PTC372188
Registration Number 372188
Incorporation Date 25 November 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0117411
Recognitions & Rankings of Den Mark Pharmaceuticals
Contact details
Den Mark Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is denmarkpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1st Floor Harish Textiles Parsi Panchayat Road Andheri East Mumbai City, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Den Mark Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Den Mark Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Den Mark Pharmaceuticals operates one associated brand: Den Mark Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical contract manufacturing and global services in India. | denmarkpharma.com |
Business activity
The main business activity of Den Mark Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Den Mark Pharmaceuticals Private Limited, buy the company report.
Financials of Den Mark Pharmaceuticals Private Limited
FY 2024 filings availableDen Mark Pharmaceuticals Private Limited reported revenue of ₹23.71 Cr (up 317% YoY) for FY 2024.
Revenue · FY 2024
₹23.71 Cr ▲ 317%
Net loss · FY 2024
₹15.96 Cr margin -67.3%
EBITDA · FY 2024
-₹13.52 Cr margin -57%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 317%
Revenue rose 317% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹23.71 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹13.52 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹15.96 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -57% | ||
| Net Profit Margin | -67.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Den Mark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Den Mark Pharmaceuticals Private Limited
Den Mark Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samad Hussain Patanwala Also directs: Crystal Medicines Private Limited | Director | 25 Nov 2021 | 4 Years 11 Months | Current |
| Shahnazar Also directs: Denmark Pharma Lifescience Private Limited | Director | 04 Apr 2022 | 4 Years 6 Months | Current |
Auditor
Den Mark Pharmaceuticals Private Limited is audited by DEEPAK G SONI & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DEEPAK G SONI & CO | FY 2024 | 135862W |
Shareholding
The shareholding of Den Mark Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Den Mark Pharmaceuticals Private Limited, buy the company report.
Legal cases
Den Mark Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Total cases
3
Filed against the company
3
Pending
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
| District courts | 1 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharma Laboratories Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Shalina Laboratories Private Limited | Pending |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by Rajshri Deepak Shinde , Drug Inspector, State of Maharashtra | Pending |
To see the full case history of Den Mark Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Den Mark Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2023, listing 82 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Pharma Impex Laboratories Pvt Ltd | |||
| Alben Chemicals Private Limited | |||
| Sorbax Pharmaceuticals Private Limited | |||
| Cian Healthcare Limited |
To see the full MSME payment records of Den Mark Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Den Mark Pharmaceuticals Private Limited has a workforce of 137 employees on its EPFO records as of Mar 24, 2025, across 1 active EPFO establishment.
Employee count
137
Active EPFO establishments
1
Employee growth
114.06%
GST
Den Mark Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICD9226A1ZT | Maharashtra | Active | 27 Dec 2021 |
| 05AAICD9226A1ZZ | Uttarakhand | Active | 09 May 2022 |
To see the full GST registrations and return filing status of Den Mark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Den Mark Pharmaceuticals Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Rida Samad Patanwala ceased to be Director on 03 Dec 2024.
Ceased
Rida Samad Patanwala ceased to be Director.
AGM
Den Mark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Den Mark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Shahnazar ceased to be Director Appointed In Casual Vacancy.
Appointed
Shahnazar was appointed as Director.
Appointed
Samad Hussain Patanwala was appointed as Director.
Incorporation
25 Nov 2021
Den Mark Pharmaceuticals Private Limited was registered on 25 Nov 2021 with Roc Mumbai & aged 4 years 11 months as per MCA records.
Frequently asked questions
Den Mark Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 November 2021 (5+ years old) and is registered under CIN U24304MH2021PTC372188.
Den Mark Pharmaceuticals has 2 current directors:
- Samad Hussain Patanwala - Director
- Shahnazar - Director
The latest financial statements of Den Mark Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Den Mark Pharmaceuticals is 27AAICD9226A1ZT, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AAICD9226A1ZZ (Uttarakhand).
The CIN (Corporate Identification Number) of Den Mark Pharmaceuticals is U24304MH2021PTC372188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Den Mark Pharmaceuticals has 3 court cases on record: 3 filed against it. 3 are pending. Most are in the high courts.
Den Mark Pharmaceuticals was incorporated on 25 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Rida Samad Patanwala ceased to be Director on 03 Dec 2024. Shahnazar ceased to be Director Appointed In Casual Vacancy on 21 Sep 2023. Shahnazar was appointed as Director on 04 Apr 2022. Den Mark Pharmaceuticals has 4 board changes on record in total.
Yes, Den Mark Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0117411).
Den Mark Pharmaceuticals has 3 MSME Form 1 returns on record for the period ending Sep 2023, listing 82 overdue payments to 19 micro and small suppliers. The latest return was filed on 18 Dec 2023.
Den Mark Pharmaceuticals can be reached through the website denmarkpharma.com. Its registered office is in Mumbai, Maharashtra, India.